Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors

被引:27
作者
Zugmaier, G [1 ]
Favoni, R
Jaeger, R
Rosen, N
Knabbe, C
机构
[1] Univ Marburg, Dept Hematol Oncol, D-35033 Marburg, Germany
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[4] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany
来源
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN | 1999年 / 886卷
关键词
D O I
10.1111/j.1749-6632.1999.tb09427.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:243 / 248
页数:6
相关论文
共 18 条
[1]   ANALYSIS OF THE INHIBITION OF TUMOR-METASTASIS BY SULFATED POLYSACCHARIDES [J].
COOMBE, DR ;
PARISH, CR ;
RAMSHAW, IA ;
SNOWDEN, JM .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (01) :82-88
[2]   ROLE OF BASIC AMINO-ACIDS IN THE INTERACTION OF BINDIN WITH SULFATED FUCANS [J].
DEANGELIS, PL ;
GLABE, CG .
BIOCHEMISTRY, 1988, 27 (21) :8189-8194
[3]  
Dellacono FR, 1997, AM J SURG, V174, P540
[4]  
Dirix LY, 1996, ANN ONCOL, V7, P843
[5]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[6]   UNUSUAL FUCOIDIN-BINDING PROPERTIES OF CHYMOTRYPSINOGEN AND TRYPSINOGEN [J].
JONES, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1037 (02) :227-232
[7]   NEOVASCULARIZATION IS ASSOCIATED WITH A SWITCH TO THE EXPORT OF BFGF IN THE MULTISTEP DEVELOPMENT OF FIBROSARCOMA [J].
KANDEL, J ;
BOSSYWETZEL, E ;
RADVANYI, F ;
KLAGSBRUN, M ;
FOLKMAN, J ;
HANAHAN, D .
CELL, 1991, 66 (06) :1095-1104
[8]  
MAXWELL M, 1991, CANCER RES, V51, P1345
[9]   EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN PRIMARY HUMAN RENAL TUMORS - CORRELATION WITH POOR SURVIVAL [J].
NANUS, DM ;
SCHMITZDRAGER, BJ ;
MOTZER, RJ ;
LEE, AC ;
VLAMIS, V ;
CORDONCARDO, C ;
ALBINO, AP ;
REUTER, VE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (19) :1597-1599
[10]   ELEVATED LEVELS OF AN ANGIOGENIC PEPTIDE, BASIC FIBROBLAST GROWTH-FACTOR, IN THE URINE OF PATIENTS WITH A WIDE SPECTRUM OF CANCERS [J].
NGUYEN, M ;
WATANABE, H ;
BUDSON, AE ;
RICHIE, JP ;
HAYES, DF ;
FOLKMAN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) :356-361